Navigation Links
Analyzing The Side Effects Of Sirolimus Stents

Based on findings of a recent study researchers from Sweden say they have found that implantation //of a sirolimus-eluting stent is associated with coronary vasoconstriction in areas adjacent to the treated vessel that is not seen with bare metal stents.

Sirolimus-eluting stents are widely used for percutaneous coronary interventions because of their excellent long-term clinical and angiographic outcome, however, recent concerns have been raised that the stents could lead to increased rates of stent thrombosis due to delayed or absent endothelialization.

Researchers compared endothelial function and coronary vasomotor response to exercise in 14 patients fitted with sirolimus-eluting stents and 11 control patients receiving bare metal stents. It was observed that after 6 months, the reference vessel showed an increase in exercise-induced vasodilation in both groups, with a mean increase in diameter of 13%, and no vasomotion in the stented vessel segments. In adjacent segments that were proximal and distal to the bare metal stent there were also increases in exercise-induced vasodilation of 15% and 17%, respectively. In contrast, exercise-induced vasoconstriction - indicating endothelial dysfunction - occurred with the sirolimus-eluting stent at these locations, with decreases in vessel diameter of 12% and 15%, respectively (p<0.001 vs controls). Vasodilatory capacity was preserved, with sublingual nitroglycerin associated with maximal vasodilation of these vessel segments in both groups.

Researchers are of the opinion that Paradoxic vasoconstriction in a vessel segment not subjected to percutaneous transluminal coronary angioplasty barotrauma may be due to diffusion of the antiproliferative drug from the stent to the peri-stent region, inducing endothelial dysfunction. However some are of the opinion that inadequate endothelial coverage could lead to insufficient nitric oxide to promote normal vasodilation with exercise. In concl usion researchers say that they will not be able to come to any positive finding, until further studies are done in this field.

For more information read:


Related medicine news :

1. Analyzing The Side Effects Of Some Common Medications
2. Analyzing The Risk Factors For Diabetic Neuropathy
3. Analyzing Client-Centered Therapy.
4. Acupuncture May Help Chemotherapy Side Effects
5. Chemotherapy Pill Has Fewer Side Effects Than IV
6. Therapy Boosts Chemotherapy Effects
7. Smoking and its Effects
8. Reducing The After Effects of Tonsillectomy
9. The Side Effects Of Estrogen Therapy
10. The Harmful Effects Of Cigarette Smoke
11. Lung Therapy Found To Have Long-Term Side Effects
Post Your Comments:

(Date:11/28/2015)... ... ... 30th at 6:00 a.m. EST until 11:59 p.m. EST, customers will be ... 20% off orders $80 or more to free gifts with purchases, there will be a ... competitive e-commerce website for skin care and cosmetic needs, customers will save on already discounted ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... PITTSBURGH, PA (PRWEB) , ... November 27, 2015 ... ... to be a safe and convenient way to dispense prescription medications at home, ... safe and effective way to monitor and dispense prescription medications. In doing so, ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set of ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 27, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), ... biopharmaceuticals company UCB S.A. (Euronext: UCB). ... acquired KU from UCB for total consideration of ... a customary working capital adjustment, a deduction of ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... , November 26, 2015 ... potential to use SyMRI to find optimal contrast weighting of ... tumor metastases, and has signed a research agreement with SyntheticMR ... the hospital. Using SyMRI, it is possible to generate multiple ... settings after the patient has left, thus making it possible ...
Breaking Medicine Technology: